Forbes reporter Lauren Silva dives into the science behind rare cannabinoid, cannabinol, also known as CBN. The article features clinical and preclinical research conducted on CBN, including InMed’s studies.
Excerpt:
What Is CBN?
Cannabinol (CBN) is a cannabinoid found in the cannabis sativa plant. It can also be produced synthetically.
CBN forms when THC degrades due to exposure to heat, air and/or light. “This is why higher levels of CBN can be found in aged, dry cannabis,” says Eric Adams, CEO, president and director of InMed Pharmaceuticals, a manufacturer and developer of rare cannabinoids. However, CBN isn’t known to cause the intoxicating psychoactive effects associated with THC.
CBD vs. CBN: What’s the Difference?
Cannabidiol (CBD) is one of the most popular cannabinoids found in cannabis sativa plants. Although similar to CBN, CBD isn’t derived directly from THC, but rather exists independently within the plants.
CBD has been studied more extensively in clinical settings than CBN, and it’s more popular in mainstream retail products. Research supports several therapeutic benefits of CBD, but CBN can’t quite compete with that list just yet.
Read full article in Forbes Health.
